Regulatory Affairs
FDA strategy and submissions across the 510(k), De Novo, PMA and Breakthrough Device pathways, and the quality system behind them.
What we do
Our work includes
- FDA pathway assessment and planning
- Pre-Submission strategy and Q-Sub preparation
- 510(k), De Novo and PMA submission support, as appropriate to the device
- Quality-system requirements and documentation
- Coordination of regulatory requirements with clinical and commercial plans
Deliverables
Typical deliverables
The scope depends on the device, intended use, development stage and existing regulatory work.
- Written pathway assessment and supporting rationale
- Pre-Submission package and meeting preparation
- Submission strategy and document plan
- Quality-system gap assessment and remediation plan
- Review of design-control and technical documentation
- Regulatory plan aligned with clinical and reimbursement milestones
Across the product lifecycle
From development to launch and growth
- DevelopmentClassification, predicate and pathway assessment; Pre-Submission planning.
- Pivotal trialIDE strategy, investigational plan alignment and FDA interactions during the study.
- Market entry510(k), De Novo or PMA submission and management of the review.
- Launch and growthSupplements, indication expansion, post-approval obligations and change management.

